Argenica Therapeutics Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

argenica.com.au

Country

Australia

Exchange

ASX

Argenica Therapeutics Limited, a biotechnology company provides the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.

Key Stats

52-Week Range

A$0.09A$0.77

Beta0.71

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.08

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.